Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV000408550 | SCV000281899 | uncertain significance | Severe early-childhood-onset retinal dystrophy | 2016-01-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000313966 | SCV000345555 | uncertain significance | not provided | 2016-09-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000313966 | SCV001074570 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001074482 | SCV001240068 | uncertain significance | Retinal dystrophy | 2017-09-15 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001101754 | SCV001258391 | uncertain significance | ABCA4-Related Disorders | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Gene |
RCV000313966 | SCV001847824 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000313966 | SCV002496898 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | ABCA4: BP4, BP7 |